| Vitamin-D deficiency as a potential environmental risk factor in multiple sclerosis, schizophrenia, and autism E Kočovská, F Gaughran, A Krivoy, UC Meier Frontiers in psychiatry 8, 47, 2017 | 116 | 2017 |
| Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial A Krivoy, R Onn, Y Vilner, E Hochman, S Weizman, A Paz, S Hess, ... EBioMedicine 26, 138-145, 2017 | 83 | 2017 |
| Does a clerkship in psychiatry contribute to changing medical students’ attitudes towards psychiatry? T Fischel, H Manna, A Krivoy, M Lewis, A Weizman Academic Psychiatry 32, 147-150, 2008 | 80 | 2008 |
| Carbamate poisoning: treatment recommendations in the setting of a mass casualties event Y Rosman, I Makarovsky, Y Bentur, S Shrot, T Dushnistky, A Krivoy The American journal of emergency medicine 27 (9), 1117-1124, 2009 | 79 | 2009 |
| Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study A Krivoy, A Weizman, L Laor, N Hellinger, Z Zemishlany, T Fischel European Neuropsychopharmacology 18 (2), 117-121, 2008 | 79 | 2008 |
| The possible involvement of metabotropic glutamate receptors in schizophrenia A Krivoy, T Fischel, A Weizman European Neuropsychopharmacology 18 (6), 395-405, 2008 | 66 | 2008 |
| Development and validation of a machine learning‐based postpartum depression prediction model: A nationwide cohort study E Hochman, B Feldman, A Weizman, A Krivoy, S Gur, E Barzilay, H Gabay, ... Depression and anxiety 38 (4), 400-411, 2021 | 63 | 2021 |
| Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior R Barzilay, T Lobel, A Krivoy, D Shlosberg, A Weizman, N Katz European psychiatry 31, 8-12, 2016 | 57 | 2016 |
| Pharmacologic prophylaxis against nerve agent poisoning I Layish, A Krivoy, E Rotman, A Finkelstein, Z Tashma, Y Yehezkelli Isr Med Assoc J 7 (3), 182-187, 2005 | 57 | 2005 |
| Medical management of toxicological mass casualty events G Markel, A Krivoy, E Rotman, O Schein, S Shrot, T Brosh-Nissimov, ... The Israel Medical Association journal 10 (11), 761, 2008 | 54 | 2008 |
| Predictors of clozapine discontinuation in patients with schizophrenia A Krivoy, L Malka, T Fischel, A Weizman, A Valevski International clinical psychopharmacology 26 (6), 311-315, 2011 | 52 | 2011 |
| The impact of age and gender on adherence to antidepressants: a 4-year population-based cohort study A Krivoy, RD Balicer, B Feldman, M Hoshen, G Zalsman, A Weizman, ... Psychopharmacology 232, 3385-3390, 2015 | 49 | 2015 |
| Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study S Gur, S Weizman, B Stubbs, A Matalon, J Meyerovitch, H Hermesh, ... Psychiatry research 260, 177-181, 2018 | 47 | 2018 |
| Sodium valproate and clozapine induced neutropenia: a case control study using register data S Malik, J Lally, O Ajnakina, M Pritchard, A Krivoy, F Gaughran, H Shetty, ... Schizophrenia research 195, 267-273, 2018 | 45 | 2018 |
| Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study A Krivoy, RD Balicer, B Feldman, M Hoshen, G Zalsman, A Weizman, ... The Journal of Clinical Psychiatry 77 (5), 443, 2016 | 45 | 2016 |
| Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment S Shrot, E Ramaty, Y Biala, G Bar-Klein, M Daninos, L Kamintsky, ... Toxicology 323, 19-25, 2014 | 42 | 2014 |
| The possible use of oximes as antidotal therapy in organophosphate-induced brain damage S Shrot, G Markel, T Dushnitsky, A Krivoy Neurotoxicology 30 (2), 167-173, 2009 | 42 | 2009 |
| Correlates of vitamin D in psychotic disorders: a comprehensive systematic review J Adamson, J Lally, F Gaughran, A Krivoy, L Allen, B Stubbs Psychiatry research 249, 78-85, 2017 | 40 | 2017 |
| Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: a nationwide cohort study G Shoval, RD Balicer, B Feldman, M Hoshen, G Eger, A Weizman, ... Depression and anxiety 36 (10), 921-929, 2019 | 39 | 2019 |
| The use of granulocyte colony-stimulating factor in clozapine rechallenge: a systematic review J Lally, S Malik, A Krivoy, E Whiskey, DM Taylor, FP Gaughran, ... Journal of Clinical Psychopharmacology 37 (5), 600-604, 2017 | 39 | 2017 |
